Vaxjo

• SGLT2 inhibitor or metformin as standard treatment in early type 2 diabetes (SMARTEST) Pending
  2024-516228-33-00 6 Type 2 Diabetes
• Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control … Recruiting
  2023-503447-33-00 4 2025-11-13 febrile Urinary Tract Infection (fUTI)
• EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure … Recruiting
  2025-521188-11-00 5 2025-10-15 Type 2 diabetes
• Optimizing endocrine treatment > 5 years after surgery for breast cancer patients: a registry-based randomized clinical trial Recruiting
  2023-506135-14-00 11 2025-09-10 Breast cancer
• A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu … Recruiting
  2023-506460-14-00 5 2025-05-07 Chronic kidney disease (CKD) and hypertension.
• Concomitant HPV vaccination and HPV screening for rapid elimination of HPV infection and cervical cancer in Sweden Recruiting
  2024-518857-41-00 6 2024-11-29 HPV infection and related diseases, such as cervical intraepithelial n
• Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting
  2023-509994-22-00 5 2024-11-15 cutaneous malignant melanoma
• SMILe: Spinal Morphine or Intravenous Lidocaine in robot-assisted upper urologic surgery Recruiting
  2023-505941-21-00 5 2024-04-09 Renal or ureter malignancy; Renal or ureter benign tumor; Nephrolithia
• A Randomized Trial of Trastuzumab Deruxtecan and Biology-Driven Selection of Neoadjuvant Treatment for HER2-positive Breast Cancer Recruiting
  2022-501504-95-00 4 2023-06-23 Non-metastatic HER2-positive Breast Cancer
• SACK Recruiting
  2022-501600-10-00 5 2023-02-07 Atrial fibrillation and Chronic Kidney Disease stage 5
• A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers Recruiting
  2024-512612-22-00 5 2021-12-09 Diabetic Foot Ulcer
• OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting
  2023-507164-39-00 6 2021-12-01 Induction of labour
• The SANT-study - A randomized controlled clinical trial of Streptococcus group A-negative acute tonsillitis in primary health care - a compa … Recruiting
  2023-508542-18-00 6 2019-09-02 Tonsilitis
• ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer Recruiting
  2023-506857-40-00 5 2019-01-08 Prostate Cancer
• EVOLVE-MI Ended recruitment
  2023-509268-26-00 6 2024-01-08 Dyslipidemia
• Phase Ib/III Study of Capivasertib + CDK4/6 Inhibitors + Fulvestrant as Treatment for Advanced/Metastatic HR+/HER2-Breast Cancer (CAPItello- … Ended recruitment
  2023-504997-39-00 5 2021-06-14 Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2
• Trastuzumab deruxtecan (T-DXd) with or without Pertuzumab versus Taxane, Trastuzumab and Pertuzumab as First-line Treatment in HER2-positive … Ended recruitment
  2023-505249-24-00 5 2021-05-27 HER2-positive metastatic breast cancer
• Adjuvant instillations in intermediate risk NMIBC: A Study comparIng Gemcitabine and MitomYciN (SIGYN-trial) Ended recruitment
  2023-504945-30-00 5 2021-03-16 Primary or recurrent non-muscle invasive bladder cancer with intermedi
• A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early … Ended recruitment
  2022-501102-35-00 5 2019-12-02 Early triple negative breast cancer
• Irinotecan-based triplet (FOLFOXIRI) as perioperative treatment in resectable gastric and gastroesophageal junction adenocarcinoma - a phase … Ended recruitment
  2023-509044-96-00 4 2018-12-21 Resectabel gastric and gastroesophageal junction adenocarcinoma

Showing 1–20 of 20 trials